Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 25
- News Article
- News Article PharmAbcine is sponsoring THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.
- Manager
- 14 Jan 2019
- Views780
- 1
- 24
- News Article
- News Article Dr. Lawrence Cher is presenting Tanibirumab phase IIa interim data at THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.
- Manager
- 14 Jan 2019
- Views816
- 1
- 23
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine is attending to THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.
- Manager
- 14 Jan 2019
- Views796
- 1
- 22
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine is joining for the ``Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology``...
- Manager
- 14 Jan 2019
- Views753
- 1
- 21
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting...
- Manager
- 14 Jan 2019
- Views915
- 1
- 20
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine and Dr. Sung Woo Kim, Head of Business Development are requested to participate partnering meeting with Novartis BD&L on September 15th, 2017.
- Manager
- 14 Jan 2019
- Views888
- 1
- 19
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine will present as invited speaker at NOVARTIS GLOBAL PARTNERING CONFERENCE on September 14th, 2017.
- Manager
- 14 Jan 2019
- Views770
- 1
- 18
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present as panelist at KoNECT-KDDF GLOBAL CLINICAL DEVELOPMENT FORUM on August 17th, 2017.
- Manager
- 14 Jan 2019
- Views806
- 1
- 17
- News Article
- News Article Dr. Lawrence Cher at Olivia Newton-Johns Cancer Wellness & Research Center/Austin Hospital is invited to present the interim data of Tanibirumab phase IIa recurrent GBM trial...
- 관리자
- 14 Jan 2019
- Views751
- 0
- 16
- News Article
- News Article PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.
- Manager
- 14 Jan 2019
- Views934
- 1